DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Friday.

XRAY has been the topic of a number of other research reports. Wells Fargo & Company cut their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday. Mizuho began coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price target on the stock. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating on the stock in a report on Friday. Morgan Stanley cut their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. Finally, Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Eleven analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $23.58.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $16.55 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business has a 50 day moving average of $18.83 and a two-hundred day moving average of $21.50. DENTSPLY SIRONA has a 52 week low of $16.21 and a 52 week high of $34.91. The company has a market cap of $3.29 billion, a P/E ratio of -8.00, a PEG ratio of 1.80 and a beta of 0.96.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Vise Technologies Inc. acquired a new position in DENTSPLY SIRONA in the fourth quarter worth approximately $195,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in DENTSPLY SIRONA by 13.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier’s stock worth $10,466,000 after buying an additional 65,308 shares during the last quarter. Voloridge Investment Management LLC acquired a new position in DENTSPLY SIRONA in the fourth quarter worth approximately $24,571,000. Tidal Investments LLC grew its position in DENTSPLY SIRONA by 15.5% in the fourth quarter. Tidal Investments LLC now owns 25,702 shares of the medical instruments supplier’s stock worth $488,000 after buying an additional 3,449 shares during the last quarter. Finally, True Wealth Design LLC grew its position in DENTSPLY SIRONA by 866.7% in the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 1,950 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.